Potent drug candidate could transform liver disease treatment
Scientists from Gwangju Institute of Science and Technology in Korea have discovered compound 11c, a potentially ground-breaking oral treatment for metabolic dysfunction-associated steatohepatitis. Their research signals a transformative leap in liver disease management, addressing both inflammation and fibrosis. 11c exhibited potent anti-inflammatory and fibrotic… Read More